Demoralization Is ‘Part of Vision’ of Care for Cancer Patients

August 3, 2016

(Medscape) – Demoralization is becoming increasingly recognized in the palliative care setting as a clinical problem that requires assessment and treatment. Prevalence rates range from 13% to 18% in patients with progressive diseases such as cancer. Defined as a “maladaptive coping response conceptualized as a loss of meaning and purpose, with feelings of hopelessness and helplessness,” the phenomenon can be treated, say researchers who report the refinement of a tool to measure demoralization.